Vismodegib (GDC-0449)

Catalog No.S1082

For research use only.

Vismodegib (GDC-0449) is a potent, novel and specific hedgehog inhibitor with IC50 of 3 nM and also inhibits P-gp with IC50 of 3.0 μM in a cell-free assay.

Vismodegib (GDC-0449) Chemical Structure

CAS No. 879085-55-9

Selleck's Vismodegib (GDC-0449) has been cited by 172 publications

Purity & Quality Control

Choose Selective Hedgehog/Smoothened Inhibitors

Other Hedgehog/Smoothened Products

Biological Activity

Description Vismodegib (GDC-0449) is a potent, novel and specific hedgehog inhibitor with IC50 of 3 nM and also inhibits P-gp with IC50 of 3.0 μM in a cell-free assay.
Targets
Hedgehog [1]
(Cell-free assay)
3 nM
In vitro

GDC-0449 targets the Hedgehog signaling pathway, blocking the activities of the Hedgehog-ligand cell surface receptors PTCH and/or SMO and suppressing Hedgehog signaling. GDC-0449 prevents multiple ATP-binding cassette (ABC) transporters. GDC-0449 also blocks ABCG2, Pgp, and MRP1-important ABC transporters associated with MDR. GDC-0449 is a potent inhibitor of ABC transporters, ABCG2/BCRP and ABCB1/Pgp, and is a mild inhibitor of ABCC1/MRP1. In ABCG2-overexpressing HEK293 cells, GDC-0449 increases retention of the fluorescent ABCG2 substrate BODIPY-prazosin and resensitizes these cells to mitoxantrone. In Madin-Darby canine kidney II cells engineered to overexpress Pgp or MRP1, GDC-0449 increases the retention of calcein-AM and resensitizes them to colchicine. GDC-0449 also resensitizes human non-small cell lung carcinoma cells NCI-H460/par and NCI-H460/MX20, which overexpress ABCG2 in response to mitoxantrone, to mitoxantrone, and to topotecan or SN-38. The IC50 values of GDC-0449 for prevention of ABCG2 and Pgp are about 1.4 μM and 3.0 μM, respectively. [2] GDC-0449 alters intracellular Ca2+ homeostasis and inhibits cell growth in cisplatin-resistant lung cancer cells. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
IGROV-1 NEHIR5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFe1fYtKSzVyPUCuNFczPDhizszN MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQly0O|M1OTdxJ{7TRW5ITVJ:L3G+
HCE-T M3PHc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml;WTWM2OD1zLkOyNlQ4KM7:TR?= MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQly0O|M1OTdxJ{7TRW5ITVJ:L3G+
D-542MG MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVzJR|UxRTFwOE[3N|ch|ryP M13IPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
23132-87 NWS1ZmxpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mnz1TWM2OD12LkSwNVQ4KM7:TR?= NWP0dYd5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNPDd|NEG3M{c,W0GQR1XSQE9iRg>?
HDLM-2 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{S1U2lEPTB;OD6wOFc3PiEQvF2= M1vmXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
ACN MknLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M365WGlEPTB;OD61NFExQSEQvF2= NGX2ZZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
HuO-3N1 NVvPPGlpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmHuTWM2OD17Lk[wNVA5KM7:TR?= NGLmb5Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
BHT-101 MmfxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF\Qd2NKSzVyPUGxMlM5KM7:TR?= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQly0O|M1OTdxJ{7TRW5ITVJ:L3G+
KYSE-150 NF\kTXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1HSdWlEPTB;MUGuOVg1OSEQvF2= NHTZbpU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
MC-IXC M4rTRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW\WRY1iUUN3ME2xNk4zOjl{IN88US=> NYrmd29mRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNPDd|NEG3M{c,W0GQR1XSQE9iRg>?
D-423MG MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlvRTWM2OD1zMj63OlU4KM7:TR?= MmP3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
NY Mo\LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEnId4hKSzVyPUG0Mlg6ODNizszN MlzOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
HOS MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3kTWM2OD1zNT62O|E6KM7:TR?= M3nMeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
NB7 MnrWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXjJR|UxRTF3Lki5NUDPxE1? MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQly0O|M1OTdxJ{7TRW5ITVJ:L3G+
DMS-273 NHvT[FJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYTJR|UxRTF4Lk[3NVMh|ryP M2DzN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
MDA-MB-361 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2SydmlEPTB;MUeuNlcyOSEQvF2= MofFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
DU-145 MkXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13pc2lEPTB;MUiuN|Ih|ryP NIfod4w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
NCI-H82 MlT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIHzXYVKSzVyPUG5Mlg{QDZizszN MnfuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
NCI-SNU-1 NEHFOlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlLYTWM2OD1{MD6wNVk3KM7:TR?= MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQly0O|M1OTdxJ{7TRW5ITVJ:L3G+
GCT NFPuNYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXHHNnJVUUN3ME2yNE45QDJ2IN88US=> NFz6epY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
C2BBe1 M17IO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4\1cWlEPTB;MkGuNVA2QCEQvF2= M{\jclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
LB2241-RCC NIq4VI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWC3[3lJUUN3ME2yNU45PDRzIN88US=> NY\6SJd6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNPDd|NEG3M{c,W0GQR1XSQE9iRg>?
COLO-829 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1XE[2lEPTB;MkKuNVg4OSEQvF2= M2S5cFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
EW-11 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUnvZ3l2UUN3ME2yNk45ODJ{IN88US=> NV:zV2gxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNPDd|NEG3M{c,W0GQR1XSQE9iRg>?
NCI-H526 NVPsUYF2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1K1e2lEPTB;MkOuOFcyPyEQvF2= M4DoO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
SF295 Mn;OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnPKTWM2OD1{ND6wNlUzKM7:TR?= M2fuelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
D-566MG MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoS0TWM2OD1{NT6yPVQ{KM7:TR?= NUTDNHM6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNPDd|NEG3M{c,W0GQR1XSQE9iRg>?
8505C M1e5Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTJ3Lk[zN|Eh|ryP NVu5VIoyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNPDd|NEG3M{c,W0GQR1XSQE9iRg>?
HT-29 MlzRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX7JR|UxRTJ4LkC0N|Eh|ryP M1vrO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
NBsusSR MkG1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3HJV2lEPTB;Mk[uPFAxPiEQvF2= M4LDeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
BV-173 M2nPZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MW\JR|UxRTJ6LkOxPFIh|ryP M1;kSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
CTB-1 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVv1VGx5UUN3ME2zNE4yODNzIN88US=> NIK0e|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
JAR NFqwc3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFjrWWpKSzVyPUOyMlU{PzFizszN NITuUGM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
CAMA-1 NHH5dpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVzJR|UxRTN|LkS2NVUh|ryP NHvhPYE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
CAL-51 M2L4XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXTsXlB2UUN3ME2zOE44OTd4IN88US=> M3\qTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
A172 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXztVnNLUUN3ME2zO{41QTJzIN88US=> M2PuVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
QIMR-WIL NGXvSGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVLO[G1XUUN3ME2zPE4xPzB6IN88US=> M3rRPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
AsPC-1 Mn7uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmH6TWM2OD1|OD60OlUyKM7:TR?= NXjDSIY2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNPDd|NEG3M{c,W0GQR1XSQE9iRg>?
MKN7 M3nabGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3;hdWlEPTB;M{muNFA4QSEQvF2= M17NUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
ONS-76 NHjYdHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1rqS2lEPTB;NEOuN|A2PyEQvF2= MmfiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
RS4-11 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUHJR|UxRTR2LkC3OVIh|ryP NID3R4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
NOS-1 M{XxdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4TwcGlEPTB;NESuOlA{OSEQvF2= MofxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
A101D NUHnR4toT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mm\hTWM2OD12ND64NFI{KM7:TR?= M33KU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
HCC1806 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTR4LkGxOFgh|ryP Ml2xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
CAL-27 MlzHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUXGR2ZPUUN3ME20O{44OjR4IN88US=> MlSyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
BT-549 MlvoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nndWlEPTB;NEiuOVMyPSEQvF2= MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQly0O|M1OTdxJ{7TRW5ITVJ:L3G+
LCLC-97TM1 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFjVWIhKSzVyPUS5MlI1OTNizszN MoTYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMOFc{PDF5Lze+V2FPT0WUPD;hQi=>
A4-Fuk M1roTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVzreIZxUUN3ME20PU45PDlizszN MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQly0O|M1OTdxJ{7TRW5ITVJ:L3G+
OVCAR-4 M2D5e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDBRYZKSzVyPUWwMlA3ODFizszN M2ezRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
HD-MY-Z M3vkc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M331PWlEPTB;NUCuO|c3PCEQvF2= NGPqcVU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmw1PzN2MUevK|5USU6JRWK8M4E,
NCI-H292 NFfERZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlrzTWM2OD13MD64O|U5KM7:TR?= M3u1e|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFQ4OzRzNz:nQnNCVkeHUkyvZV4>
Sk-ChA-1  MnvtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml\uNE4zPeLCk{WwJO69VQ>? M4L1NFczKGh? MVLJR|UxRTd2LkW0xtEzNjV6zszN M4XSXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{SyOFgzLz5{NUe0NlQ5OjxxYU6=
Mz-ChA-1 NEf1cmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUDJZW5qOC5{NfMAl|UxKM7:TR?= MlvYO|IhcA>? NXKzdpJGUUN3ME21OE46P8LzMz60Oe69VQ>? M{jXZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{SyOFgzLz5{NUe0NlQ5OjxxYU6=
Smo-WT M2H5PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MofhTWM2OMLib3[gNVTDqG6P MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDJ7MUGwOEc,OjR{OUGxNFQ9N2F-
Smo-D473H  M3rWbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmXOTWM2OMLib3[gO{4yyqEQvF2= NYLST41FRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSyPVEyODRpPkK0NlkyOTB2PD;hQi=>
K562 M1HnfmZ2dmO2aX;uJGF{e2G7 NEH1WJkyOCEQvF2= MlXvO|IhcA>? NIK2VI9z\WS3Y3XzJJRp\SCneIDy[ZN{cW:wIH;mJGdtcTIEoB?= M2rBVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{G5PFI1Lz5{M{OxPVgzPDxxYU6=
T315I BCR-ABL BaF3 MUjGeY5kfGmxbjDBd5NigQ>? MoT0NVAh|ryP MXq3NkBp NWrlR|E1emWmdXPld{B1cGViZYjwdoV{e2mxbjDv[kBIdGlzwrC= NHTOZoY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OxPVgzPCd-MkOzNVk5OjR:L3G+
TF-1 BCR-ABL NXLMZ2NUTnWwY4Tpc44hSXO|YYm= M4OyTlExKM7:TR?= MV23NkBp MVfy[YR2[2W|IITo[UBmgHC{ZYPzbY9vKG:oIFfsbVHDqA>? MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzNzOUiyOEc,OjN|MUm4NlQ9N2F-
Shh-Light 2 NGL4fZFHfW6ldHnvckBie3OjeR?= NI[4RnQzKGSjeYO= M3zyXGFvfGGpb37pd5Qh[WO2aY\peJkh[XRiU33vJIlvKG2xdYPlJHNpcC2OaXfoeEAzKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gV4hpNWmwZIXj[YQhT2yrMT3y[ZBwenSncjDhZ5Rqfmm2eTDh[pRmeiB{IHThfZMh[nliZIXhcE1tfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgcYV1cG:mLDDJR|UxKD1iMD6wNFE2KM7:TT6= M3PQVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|ME[zOVIzLz5{M{C2N|UzOjxxYU6=
NIH/3T3 M1frO2Z2dmO2aX;uJIF{e2G7 MVXJcohq[mm2aX;uJI9nKGinZHflbI9oKHOrZ37hcIlv\yBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDtc5V{\SCQSVivN3Q{KGOnbHzzJIJ6KEeuaT3keYFtNWy3Y3nm[ZJie2VicnXwc5J1\XJiYYPzZZktKEmFNUCgQUAxNjByMkOg{txONg>? MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzF6MECxNkc,OjdzOECwNVI9N2F-
NIH/3T3 Light2 NUPuXWZqTnWwY4Tpc44h[XO|YYm= MkXpTY5pcWKrdHnvckBw\iCqZXTn[Yhw\yC|aXfuZYxqdmdicHH0bJdigSCrbjDtc5V{\SCQSVivN3Q{KEyrZ3j0NkBk\WyuczDifUBIdGlvbIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBKSzVyIE2gNE4xODJ|IN88UU4> NVTC[It5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki2PFgzPzhpPkK4Olg5Ojd6PD;hQi=>
Light2 MYfGeY5kfGmxbjDhd5NigQ>? Mki4OFghcHK| NHrsfYRKdmirYnn0bY9vKG:oIHjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJI1wfXOnIFzp[4h1OiClZXzsd{Bi\nSncjC0PEBpenNiYomgS4xqNWy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OCB;IECuNFAzPDZizszNMi=> M2G1ZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7N{O5O|E1Lz5{OUezPVcyPDxxYU6=
HEPM NVvoUWE{TnWwY4Tpc44h[XO|YYm= NVS4b4l6UW6qaXLpeIlwdiCxZjDTTGghcW5iaIXtZY4hUEWSTTDj[YxteyCkeTDHcIkudHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDJUmghRSByLkCwNlgh|ryPLh?= M4Tvd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7N{G2Nlk3Lz5zOUexOlI6PjxxYU6=
Shh Light2 NID4c21HfW6ldHnvckBie3OjeR?= NV3UUGZMUW6qaXLpeIlwdiCxZjDTTGghcW5ibX;1d4UhW2iqIFzp[4h1OiClZXzsd{BjgSCJTFmtdoV{eG:wc3n2[UBncXKnZnz5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiSVO1NEA:KDBwMECzJO69VS5? MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTNyOUC4NEc,OTl|MEmwPFA9N2F-
HEPM NVXTbHhnTnWwY4Tpc44h[XO|YYm= NWm4VZRwUW6qaXLpeIlwdiCxZjDI[YRo\WixZzDzbYdv[WyrbnegbY4hcHWvYX6gTGVRVSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gdoVk\XC2b4KtcYVlcWG2ZXSgS4xqOSCvUl7BJIV5eHKnc4Ppc44h[nlicnXwc5J1\XJiZ3Xu[UBie3OjeTygTW5JKD1iMD6wNFMh|ryPLh?= M3rq[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyOEe1O|QyLz5{MEi3OVc1OTxxYU6=
C3H10T1/2 NEj5SWVHfW6ldHnvckBie3OjeR?= M4fofVIxKGi{cx?= MkC5TY5pcWKrdHnvckBw\iCVbX:gbY4hdW:3c3WgR|NJOTCWMT:yJINmdGy|IIXzbY5oKGi3bXHuJJJm[2:vYnnuZY51KFOKSDDhd5Nme3OnZDDhd{Bm\m[nY4Sgc44hW02RL2PITEB1emGwc3nlcpQhfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44h[W[2ZYKgNlAhcHK|IHL5JGdtcS2udXPp[oVz[XOnIILldI9zfGW{IHHzd4F6NCCLQ{WwJF0hOC5yMEWg{txONg>? MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMESzOkc,OjR7MEC0N|Y9N2F-
NIH/3T3 MV\GeY5kfGmxbjDhd5NigQ>? NFvjN44zPCCqcoO= NX:3OoM4UW6qaXLpeIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeTDpckBud3W|ZTDOTWgwO1R|IHPlcIx{KG2nYYP1doVlKGGodHXyJFI1KGi{czDifUBIdGlvZIXhcEBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFnDOVAhRSByLkCwOUDPxE1w NFfsV3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{ixNFU6OSd-Mke4NVA2QTF:L3G+
NIH3T3 M4L2dWZ2dmO2aX;uJIF{e2G7 MYS0PEBpenN? NV;Xb|J[UW6qaXLpeIlwdiCxZjDzcY8udWWmaXH0[YQhcGWmZ3Xoc4che2mpbnHsbY5oKHCjdHj3ZZkhcW5ibX;1d4UhVkmKM2SzJINmdGy|IHX4dJJme3OrbnegS3JGNUy3YzDy[ZBwenSncjDn[Y5mKGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhW0GJLXnu[JVk\WRiR2LFMWx2[yC{ZYDvdpRmeiCjY4Tpeol1gSCjZoTldkA1QCCqcoOgZpkhdHWvaX7ld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOC5yME[g{txONg>? NYjq[4xSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0PVk1QDNpPkK5OFk6PDh|PD;hQi=>
Shh-light2 MV7GeY5kfGmxbjDhd5NigQ>? NXG1[455UW6qaXLpeIlwdiCxZjDTcY8udWWmaXH0[YQhUGhic3nncoFtcW6pIHnuJIh2dWGwIGPobE1tcWeqdEKgZ4VtdHNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCLQ{WwJF0hOC5yMEeg{txONg>? M1fzcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{Mk[4OVUyLz5{MkK2PFU2OTxxYU6=
HEK293 NFi4d2VHfW6ldHnvckBie3OjeR?= MmDDNkBpenN? NYrBXmlFTGm|cHzhZ4Vu\W62IH;mJGJQTEmSWT3sZYJmdGynZDDjfYNtd3CjbXnu[UBnem:vIHj1cYFvKFOvbzDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHmeIVzKDJiaILzJIJ6KG[udX;y[ZNk\W6lZTDtbYNzd3Olb4D5MEBKSzVyIE2gNE4xODdizszNMi=> M3LnT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{Mk[4OVUyLz5{MkK2PFU2OTxxYU6=
NIH3T3 MkLaSpVv[3Srb36gZZN{[Xl? M4rJcmlvcGmkaYTpc44hd2ZiaHXk[4Vpd2dicnXj[ZB1d3Jic3nncoFtcW6pIIDheIh4[XliaX6gcY92e2ViTlnIN3Q{KGOnbHzzJJRz[W6|ZnXjeIVlKHerdHigS4xqNXKncH;yeIVzKGenbnWgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDJR|UxKD1iMD6wNFcyPyEQvF2u MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDl{M{e2OUc,OjR7MkO3OlU9N2F-
NIH/3T3 NGfBR3FHfW6ldHnvckBie3OjeR?= M1TTRlQ5KGi{cx?= NFnqOJBKdmirYnn0bY9vKG:oIFjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJI1wfXOnIF7JTE8{XDNiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJHNwdmmlIHjl[IdmcG:pLXnu[JVk\WRiR3zpJIx2[2moZYLhd4Uh[WO2aY\peJkh[W[2ZYKgOFghcHK|IHL5JGR2[WxvbIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBKSzVyIE2gNE4xODdzNzFOwG0v MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODJ2OUS5OEc,OzB{NEm0PVQ9N2F-
NIH3T3 NFv6[3BHfW6ldHnvckBie3OjeR?= M1vKPFQ5KGi{cx?= MnHmTY5pcWKrdHnvckBw\iCqZXTn[Yhw\yC|aXfuZYxtcW6pIHnuJI1wfXOnIF7JTFNVOyClZXzsd{B{fGGkbImgeJJidnOoZXP0[YQhf2m2aDDHcIkudHWlaX\ldoF{\SClb37zeJJ2[3RiaX7jeYJifGWmIH\vdkA1QCCqcoOgZpkh\HWjbDDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEmFNUCgQUAxNjByN{Kg{txONg>? NGrBeHk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkiyO|E{Pid-Mk[4NlcyOzZ:L3G+
NIH3T3 NWC3NnkyTnWwY4Tpc44h[XO|YYm= NVOwTm5YPDhiaILz NGDOelZKdmirYnn0bY9vKG:oIGPvcolkNWmwZIXj[YQhcGWmZ3Xoc4che2mpbnHscIlv\yCrbjDtc5V{\SCQSVizWFMh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IFfsbU1tfWOrZnXyZZNmKHKncH;yeIVzKGG|c3H5MEBKSzVyIE2gNE4xODd{IN88UU4> NG\OOWY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkiyNFU2PCd-Mk[4NlA2PTR:L3G+
NIH3T3 NYLtO|l1TnWwY4Tpc44h[XO|YYm= MUW0PEBpenN? Mn\MTY5pcWKrdHnvckBw\iCVSFigd4lodmGuaX7nJJBifGi5YYmgbY4hdW:3c3WgUmlJO1R|IHPlcIx{KG2nYYP1doVlKGGodHXyJFQ5KGi{czDifUBIdGlvbIXjbYZmemG|ZTDy[ZBwenSncjDhd5NigSxiSVO1NEA:KDBwMEC3NkDPxE1w NVXBS2ZlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxO|Y{QTZpPkK0NVc3Ozl4PD;hQi=>
NIH/3T3 NGGyNItHfW6ldHnvckBie3OjeR?= NIrHPIk1QCCqcoO= M1nMTWlvcGmkaYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XliaX6gcY92e2ViTlnIM|NVOyClZXzsd{Bi\nSncjC0PEBpenNiYomgS4xqNWy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OCB;IECuNFA4OiEQvF2u NXvaRlZQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0PFYzODNpPkK0OFg3OjB|PD;hQi=>
NIH/3T3 NGjkOoNHfW6ldHnvckBie3OjeR?= Mlq3TY5pcWKrdHnvckBw\iCqZXTn[Yhw\yC|aXfuZYxqdmdicHH0bJdigSCrbjDtc5V{\SCQSVivN3Q{KGOnbHzzJIJ6KEeuaUGtcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCLQ{WwJF0hOC5yMEeyJO69VS5? MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDRyNUewOEc,OjR2MEW3NFQ9N2F-
NIH/3T3 Mn\RSpVv[3Srb36gZZN{[Xl? NGLkXlZKdmirYnn0bY9vKG:oIHjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJI1wfXOnIF7JTE8{XDNiY3XscJMh[2G{conpcoche3SjYnz5JJRz[W6|ZnXjeIVlKEeuaT3y[ZBwenSncjDjc45{fHK3Y4SgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCjc4PhfUwhUUN3MDC9JFAvODB5MjFOwG0v NV\wNFE6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki2OFIyODFpPkK4OlQzOTBzPD;hQi=>
C3H10T1/2 MnnISpVv[3Srb36gZZN{[Xl? NEHKblU3KGi{cx?= Mom2TY5pcWKrdHnvckBw\iCVQVetbY5lfWOnZDDkbYZn\XKnboTpZZRqd25ib3[gcY92e2VibXXz[Y5kcHmvYXygdIx2emmyb4TlcpQhSzOKMUDUNU8zKGOnbHzzJJRwKGGua3HsbY5mKHCqb4PwbIF1[XOnIIDvd4l1cX[nIH;ld4Vw[myjc4TzJIFnfGW{IE[gbJJ{NCCLQ{WwJF0hOC5yMUGg{txONg>? NYjac5dVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyOlg2PTFpPkKyNlY5PTVzPD;hQi=>
HCC827 NFmxcZVHfW6ldHnvckBie3OjeR?= MoK4SIl{eGyjY3Xt[Y51KG:oIGuzTH0u[3mlbH;wZY1qdmViZoLvcUBUVU9iVkSwOG0hdXW2YX70JIlvKGenZnn0bY5q[iC{ZYPpd5RidnRiaIXtZY4hUEOFOEK3JINmdGy|IHL5JJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFvpJF0hOC5yMUKyJO69VS5? NV33XHZWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki3PFcyPTZpPkK4O|g4OTV4PD;hQi=>
C3H10T1/2 MYHGeY5kfGmxbjDhd5NigQ>? Mly3TY5pcWKrdHnvckBw\iCVSFigbY4hdW:3c3WgR|NJOTCWMT:yJINmdGy|IHL5JGdtcS2udXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGlEPTBiPTCwMlAyOyEQvF2u MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTdzNkK5Okc,OTl5MU[yPVY9N2F-
S12 NEnUWGNHfW6ldHnvckBie3OjeR?= NGP5U|hKdmirYnn0bY9vKG:oIFjl[IdmcG:pIIPp[45idGmwZzDpckBud3W|ZTDTNVIh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIILlZ4VxfG:{LX3l[IlifGWmIFfsbVEhdVKQQTDlfJBz\XO|aX;uJIJ6KHKncH;yeIVzKGenbnWgZZN{[XluIFnOTEA:KDBwMEGzJO69VS5? NHP1R449[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEi3OVc1OSd-MkC4O|U4PDF:L3G+
TM3 NFHMe4NHfW6ldHnvckBie3OjeR?= MoXIOFghcHK| NHvreVRKdmirYnn0bY9vKG:oIFjoJJNq\26jbHnu[{Bx[XSqd3H5JIlvKG2xdYPlJHROOyClZXzsd{Bie3Onc4Pl[EBieyCmb4fudoVofWyjdHnvckBw\iCJbHmxJIdmdmViZYjwdoV{e2mxbjDh[pRmeiB2ODDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyIE2gNE4xOTNizszNMi=> NEe2fo09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nkm3OlIyPSd-Mk[5O|YzOTV:L3G+
NIH/3T3 NH;IbYlHfW6ldHnvckBie3OjeR?= NWHKd29NUW6qaXLpeIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeTDpckBud3W|ZTDOTWgwO1R|IHPlcIx{KGW6cILld5Nqdmdid3ns[EB1gXCnIGPtc{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gS4xqKG2UTlGg[ZhxemW|c3nvckBjgSCUVD3QR3IhdWW2aH;kMEBKSzVyIE2gNE4xOTR2IN88UU4> NWDjR2RQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke4NVA2QTFpPkK3PFExPTlzPD;hQi=>
S12 MkTiSpVv[3Srb36gZZN{[Xl? MXW0PEBpenN? M3Xyb2lvcGmkaYTpc44hd2ZiaIXtZY4hW0iKIIDheIh4[XliaX6gcY92e2ViU{GyJINmdGy|IHHzd4V{e2WmIHHzJGdNUS2vZXTpZZRm\CC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkh[W[2ZYKgOFghcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiSVO1NEA:KDBwMEG1JO69VS5? NETxWnE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSzPFUzPyd-MkG0N|g2Ojd:L3G+
NIH/3T3 M2fjN2Z2dmO2aX;uJIF{e2G7 MUHJcohq[mm2aX;uJI9nKFOPTzDpckBud3W|ZTDOTWgwO1R|IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhW0GJLXnu[JVk\WRiaHXk[4Vpd2dvbXXkbYF1\WRibIXtbY5me2OnbnPlJJNq\26jbHnu[{BjgSCJUlWtcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCLQ{WwJF0hOC5yMU[g{txONg>? MnT3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzMUm1NFAoRjJ4MUG5OVAxRC:jPh?=
U2OS MXjGeY5kfGmxbjDhd5NigQ>? NGfCVIMzKGi{cx?= MkHnSIl{eGyjY3Xt[Y51KG:oIGuzTH1kgWOub4DhcYlv\SCocn;tJJdqdGRidInw[UBUdW9iZYjwdoV{e2WmIHnuJHUzV1NiY3XscJMh[W[2ZYKgNkBpenNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yxiS3mgQUAxNjBzNkKg{txONg>? M4e2WlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|ME[zOVIzLz5{M{C2N|UzOjxxYU6=
NIH3T3 MX3GeY5kfGmxbjDhd5NigQ>? NIHWcHI{OCCqcoO= MknTTY5pcWKrdHnvckBw\iCVbX:gdoVk\XC2b4KgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO|ZXSgbY4hVkmKM2SzJINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiU33vJIFod26rc4SgV2FINWmwZIXj[YQhT1KHIHHjeIl3[XSrb36gZYZ1\XJiM{CgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhUUN3MDC9JFAvODJ|IN88UU4> M{f4e|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{K2PFA4Lz5{NEeyOlgxPzxxYU6=
medulloblastoma cell Mmm1RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? Mn;WN|YhcHK| NF7tUHJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JHB1[2htLz2gZY5lKHB3Mz2vMUBud3W|ZTDt[YR2dGyxYnzhd5RwdWFiY3XscJMh[W[2ZYKgN|YhcHK|IHL5JGJz\HViaX7jc5Jxd3KjdHnvckBie3OjeTygTWM2OCB;IECuNFMxPCEQvF2u NHmwTHM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OE[4PFI4QCd-Mki2PFgzPzh:L3G+
Shh Light2 MkHxSpVv[3Srb36gZZN{[Xl? NEWzTodCdnSjZ3;ubZN1KGGldHn2bZR6KGG2IIPtc491cGWwZXSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO|ZXSgbY4hdW:3c3WgV4hpKEyrZ3j0NkBk\WyuczDjc{1mgHC{ZYPzbY5oKEeuaT3k[ZBmdmSnboSgdoVxd3K2ZYKg[4Vv\SCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEiqIIPp[45idGmwZzDifUBlfWGuIHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhUUN3MDC9JFAvODN|IN88UU4> NYPjcYxoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0PVE1PTlpPkK0OFkyPDV7PD;hQi=>
Light2 NVnJS48{TnWwY4Tpc44h[XO|YYm= M3zTV2lvcGmkaYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XliaX6gcY92e2ViTHnnbJQzKGOnbHzzJIlvKFOqaDDjc45lcXSrb37l[EBu\WSrdX2gZpkhT2yrLXz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhUUN3MDC9JFAvODN7IN88UU4> NGf2cHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEi3N|MxOyd-Mki4O|M{ODN:L3G+
Shh Light2 M4i1fmZ2dmO2aX;uJIF{e2G7 Mo[yTY5pcWKrdHnvckBw\iCVbX:tcYVlcWG2ZXSgTIghe2mpbnHscIlv\yCyYYToe4F6KGmwIH3veZNmKFOqaDDMbYdpfDJiY3XscJMh[nliR3zpMYx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiSVO1NEA:KDBwMEO5NkDPxE1w NVrlXXhWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke3N|YxPjNpPkK3O|M3ODZ|PD;hQi=>
ASZ001 NXXRVYV4TnWwY4Tpc44h[XO|YYm= NXzjeWhRPDhiaILz M1W3bWlvcGmkaYTpc44hd2ZiSHXk[4Vpd2dic3nncoFtcW6pIHnuJI1wfXOnIFHTXlAxOSClZXzsd{Bie3Onc4Pl[EBieyCmb4fudoVofWyjdHnvckBw\iCJbHmxJI1TVkFiZYjwdoV{e2mxbjDh[pRmeiB2ODDodpMh[nliUmStVGNTKGGwYXz5d4l{NCCLQ{WwJF0hOC5yNDFOwG0v MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEexOkc,OjR7MEC3NVY9N2F-
NIH/3T3 MWjGeY5kfGmxbjDhd5NigQ>? MVe0PEBpenN? MWLBcpRi\2:waYP0JIFkfGm4aYT5JIF1KFOvbzDy[YNmeHSxcjDpckBud3W|ZTDOTWgwO1R|IHPlcIx{KGijcnLvdolv\yCJUlWtUJVkKGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhW0GJLXnu[JVk\WRiSHigd4lodmGuaX7nJJBifGi5YYmgdJJmcW6ldXLheIVlKHerdHigZ4VtdHNiZn;scI94\WRiYomgV2FIKGGmZHn0bY9vKG2nYYP1doVlKGGodHXyJFQ5KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFnDOVAhRSByLkC0OkDPxE1w NIW3SZo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUi1O|I4PSd-Mkm4OVczPzV:L3G+
Light2 MlX5SpVv[3Srb36gZZN{[Xl? M125WVMxKGi{cx?= NITDR5JKdmirYnn0bY9vKG:oIHjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJI1wfXOnIFzp[4h1OiClZXzsd{BqdiCVaHigZ49v\Gm2aX;u[YQhdWWmaYXtJIFnfGW{IEOwJIhzeyCkeTDHcIkuWmWwaXzsZUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFnDOVAhRSByLkC1JO69VS5? NGnRcnM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEC5PVI2Pyd-M{CwPVkzPTd:L3G+
C3H10T1/2 MmnFSpVv[3Srb36gZZN{[Xl? M3O1fFYh\GG7cx?= NVLDfXN6UW6qaXLpeIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeT3t[YRq[XSnZDDkbYZn\XKnboTpZZRqd25ib3[gcY92e2ViQ{PINVBVOS9{IHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJHNCTy2rbnT1Z4VlKEGOUDDhZ5Rqfmm2eTDh[pRmeiB4IHThfZMh[nliY3jlcYltfW2rbnXzZ4Vv[2VvYnHz[YQh[XO|YYmsJGlEPTBiPTCwMlA2KM7:TT6= M1nRV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMEm5NlU4Lz5|MEC5PVI2PzxxYU6=
DaOY MVTGeY5kfGmxbjDhd5NigQ>? MVS0PEBpenN? MXvJcohq[mm2aX;uJI9nKEinZHflbI9oKHOrZ37hcIlv\yCrbjDoeY1idiCGYV;ZJINmdGy|IHHzd4V{e2WmIHHzJIRwf26{ZXf1cIF1cW:wIH;mJGdtcTFibWLORUBmgHC{ZYPzbY9vKGGodHXyJFQ5KGi{czDifUBTXC2SQ2KgZY5idHm|aYOsJGlEPTBiPTCwMlA5PiEQvF2u MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEexOkc,OjR7MEC3NVY9N2F-
C3H10T1/2 NYrHeGM3TnWwY4Tpc44h[XO|YYm= NGrjeGgyKGi{ NFK2fJFKdmirYnn0bY9vKG:oIFjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJI1wfXOnIFOzTFExXDFxMjDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4heHW{bX;ydIhidWmwZT3pcoR2[2WmIHnuZ5Jm[XOnIHnuJIFtc2GuaX7lJJBpd3OyaHH0ZZNmKGyndnXsJJV{cW6pIFPEVE1{fGG{IHHzJJN2[nO2cnH0[UBxemW2cnXheIVlKG[xcjCxJIhzKG[xbHzve4VlKGK7IID1do1wenCqYX3pcoUh[WSmaYTpc44hdWWjc4Xy[YQh[W[2ZYKgOUBl[XluIFnDOVAhRSByLkG0JO69VS5? Mn\1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh7NEe5N|koRjJ6OUS3PVM6RC:jPh?=
M210B4 NXnIT2pCTnWwY4Tpc44h[XO|YYm= NI\0RnkzPCCqcoO= NWPMN4VVUW6qaXLpeIlwdiCxZjDI[YRo\WixZzDzbYdv[WyrbnegbY4hdW:3c3WgUVIyOEJ2IHPlcIx{KGG|c3Xzd4VlKGG|IHTve45z\We3bHH0bY9vKG:oIGD0Z4ghdVKQQTDlfJBz\XO|aX;uJIFnfGW{IEK0JIhzeyCkeTDSWE1RS1JiYX7hcJl{cXNuIFnDOVAhRSByLkG0JO69VS5? MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEexOkc,OjR7MEC3NVY9N2F-
M210B4 MVzGeY5kfGmxbjDhd5NigQ>? MmW3NlQhcHK| MYLJcohq[mm2aX;uJI9nKEinZHflbI9oKHOrZ37hcIlv\yCrbjDtc5V{\SCPMkGwRlQh[2WubIOgZZN{\XO|ZXSgZZMh\G:5boLl[5Vt[XSrb36gc4YhT2yrMTDtVm5CKGW6cILld5Nqd25iYX\0[ZIhOjRiaILzJIJ6KFKWLWDDVkBidmGueYPpd{whUUN3MDC9JFAvOiEQvF2u MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEexOkc,OjR7MEC3NVY9N2F-
Shh Light2 NWjXPWpYTnWwY4Tpc44h[XO|YYm= MUexJIhz NHjVblVKdmirYnn0bY9vKG:oIFjl[IdmcG:pIIPp[45idGmwZzDpckBud3W|ZTDTbIghVGmpaISyJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCydYLtc5JxcGGvaX7lMYlv\HWlZXSgS4xqKG2nZHnheIVlKHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBxemW2cnXheIVlKG[xcjCxJIhzKG[xbHzve4VlKGK7IID1do1wenCqYX3pcoUh[WSmaYTpc44hdWWjc4Xy[YQh[W[2ZYKgOFghcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiSVO1NEA:KDBwOUig{txONg>? M2ry[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUS3PVM6Lz5{OEm0O|k{QTxxYU6=
NIH/3T3 NWHDR|ZITnWwY4Tpc44h[XO|YYm= MXvJcohq[mm2aX;uJI9nKGinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGmwIH3veZNmKE6LSD:zWFMh[2WubIOgbIFz[m:{aX7nJHNudyCGNEe3TEBufXSjboSgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIFfsbUBuWk6DIHX4dJJme3Orb36gZpkhWlRvUFPSJI1mfGixZDygTWM2OCB;IEGuNVk3KM7:TT6= MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzhzMEW5NUc,Ojd6MUC1PVE9N2F-
S12 MUXGeY5kfGmxbjDhd5NigQ>? NGThNFA1QCCqcoO= NFX1fItKdmirYnn0bY9vKG:oIHj1cYFvKFOKSDDwZZRpf2G7IHnuJI1wfXOnIGOxNkBk\WyuczDhd5Nme3OnZDDhd{BIVElvbXXkbYF1\WRidILhcpNkemmydHnvcoFtKGGldHn2bZR6KGGodHXyJFQ5KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XliaX6gdJJme2WwY3Wgc4YhOC53IH3nM41NKGi3bXHuJIFteGijLUGtZYNq\CCpbInjc5Bzd3SnaX6sJGlEPTBiPTCxMlc2KM7:TT6= NWjWS5NkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0N|g2OjdpPkKxOFM5PTJ5PD;hQi=>
Calu6 NUfPXYpxTnWwY4Tpc44h[XO|YYm= MVK0JIhzew>? MVTQcIF{dWFiY3;uZ4VvfHKjdHnvckBqdiCqdX3hckBE[Wy3NjDj[YxteyC6ZX7v[5Ji\nSnZDDpckBvfWSnIH3veZNmKGG2IEe1JI1oN2upLDDwc{BjcWRibXXhd5Vz\WRiYX\0[ZIhPCCqcoOgdI9{fCCoaX\0bEBld3OnLDDDdEA:KDJ|IN88UU4> NIGzOmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUexOlI6Pid-MUm3NVYzQTZ:L3G+
Calu-6 NGDyRnhHfW6ldHnvckBie3OjeR?= NEn0UphRdGG|bXGgZ49v[2WwdILheIlwdiCrbjDDZYx2NTZiY3XscJMhgGWwb3fyZYZ1\WRiboXk[UBud3W|ZTDQT{9RTCCvb3TlcEBifCB5NTDt[{9s\yxicH:gZollKG[xcjC1JIRigXNibXXhd5Vz\WRiNDDodpMheG:|dDDsZZN1KGSxc3WgdoVt[XSrdnWgeI8hfW62cnXheIVlKGOxboTyc4wtKEOyIE2gNlMh|ryPLh?= NF\MVoE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEi3OVc1OSd-MkC4O|U4PDF:L3G+
T47D M1THPWN6fG:2b4jpZ4l1gSCjc4PhfS=> Mn3PO|IhcHK| NF7jOHhEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBVPDeGIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA1OS5|NDFOwG0v MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTFyN{SyPUc,OjlzMEe0Nlk9N2F-
LS180 M4rhOmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MXS3NkBpenN? M33mUmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTGOxPFAh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IIP1cIZwemixZHHtbY5mNUJiYYPzZZktKEmFNUCgQUA1PSEQvF2u MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODB7OUK1O{c,OzByOUmyOVc9N2F-
LS174T MXPBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M{fVZVczKGi{cx?= NGnPdnpCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFzTNVc1XCClZXzsd{Bi\nSncjC3NkBpenNiYomgR4VtdFSrdHXyMWdtdyCudX3pcoV{[2WwdDDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3MDC9JFQ2NjhzIN88UU4> M3\CTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4OEKwOVU1Lz5{NkiyNFU2PDxxYU6=
BxPC3 NEfKOlRCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M1jC[FczKGi{cx?= M4HsOWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQojQR|Mh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IFPlcIxVcXSncj3HcI8hdHWvaX7ld4NmdnRiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTBiPTC0O{46PSEQvF2u MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjh{MEW1OEc,OjZ6MkC1OVQ9N2F-
medulloblastoma cell M4DmemFvfGm2dX3vdkBie3OjeR?= NVnUN|F[SW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhdW:3c3WgcYVlfWyub3LsZZN1d22jIHPlcIx{KHinbn;ndoFnfGWmIHnuJHB1[2hiKz:tJI1wfXOnIHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKHS3bX;yJJZwdHWvZTDheEAyOi53IH3nM4toNCCybzDibYQv NGHVfZo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUexOlI6Pid-MUm3NVYzQTZ:L3G+
S12 NUTKRYk{TnWwY4Tpc44h[XO|YYm= MoPGOFghcHK| M13FTmlvcGmkaYTpc44hd2ZiaIXtZY4hW0iKIIDheIh4[XliaX6gcY92e2ViU{GyJINmdGy|IHHzd4V{e2WmIHHzJGdNUS2vZXTpZZRm\CC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkh[W[2ZYKgOFghcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSCrbjDwdoV{\W6lZTDv[kAyKG2pL33MJIh2dWGwIHHsdIhiNTFvYXPp[EBodHmlb4Dyc5RmcW5w NXnjeVdMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0N|g2OjdpPkKxOFM5PTJ5PD;hQi=>
Shh Light2 MUnGeY5kfGmxbjDhd5NigQ>? Ml:2NE4yKHWP M4rYPVM3KGi{cx?= M1u0VmlvcGmkaYTpc44hd2ZiU33vMY1m\GmjdHXkJGhpKHOrZ37hcIxqdmdicHH0bJdigSCrbjDtc5V{\SCVaHigUIlocHR{IHPlcIx{KGG|c3Xzd4VlKGG|IIP1dJBz\XO|aX;uJI9nKEeuaUGtcXJPSSCneIDy[ZN{cW:wIHH0JFAvOSC3TTDt[YF{fXKnZDDh[pRmeiB|NjDodpMh[nliUmStdXBEWiCjbnHsfZNqey5? M3LG[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5N{O2NFY{Lz5{N{ezOlA3OzxxYU6=
SW1353 Ml3tRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NIDIVWYyOCC3TR?= MV[0PEBpenN? M3:ySWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU2exN|U{KGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGG2IEGwJJVOKGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZkv NHG0WVg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NES5NVQ2QSd-MkS0PVE1PTl:L3G+
DaOY NGrnOZNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NUPrOHBpOTBidV2= NUjNbXlEPDhiaILz NXmzNmtNSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDEZW9[KGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGG2IEGwJJVOKGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZkv MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR7MUS1PUc,OjR2OUG0OVk9N2F-
A549 M4XxUWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MoHSNVAhfU1? MYC0PEBpenN? MoDTRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDNUS5JINmdGy|IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJIF1KDFyIIXNJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmu M{LiSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NEmxOFU6Lz5{NES5NVQ2QTxxYU6=
HCT116 MWjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NGrzTIIyOCC3TR?= NH3W[Gc1QCCqcoO= NG[2PXlCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFEyPiClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjdDCxNEB2VSCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6Ng>? NGLUdlU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NES5NVQ2QSd-MkS0PVE1PTl:L3G+
NIH/3T3 NXT6TmJETnWwY4Tpc44h[XO|YYm= NEXWbJQyOCC3TR?= NIDBcFlKdmirYnn0bY9vKG:oIFjl[IdmcG:pIIPp[45idGmwZzDpckBud3W|ZTDOTWgwO1R|IHPlcIx{KGG|c3Xzd4VlKGG|IHTve44hemWpdXzheIlwdiCxZjDtVHREUDFibWLORUBmgHC{ZYPzbY9vKGG2IEGwJJVONg>? M{HaV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NEmxOFU6Lz5{NES5NVQ2QTxxYU6=
MSC MnHESpVv[3Srb36gZZN{[Xl? NXfwdXBIOjBidH:gPFAhfU1? NHLNZolKdmirYnn0bY9vKG:oIHjl[IdmcG:pIIPp[45idGmwZzDpckBud3W|ZTDNV2Mh[2WubIOgZZN{\XO|ZXSgZZMh\G:5bjDy[Yd2dGG2aX;uJI9nKGGua3HsbY5mKHCqb4PwbIF1[XOnIHH0JFIxKHSxIEiwJJVONg>? MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR7MUS1PUc,OjR2OUG0OVk9N2F-
SK-N-MC MX;xTHRUKGG|c3H5 MYjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucz6= NEH4XFk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
TC32 M{T1dpFJXFNiYYPzZZk> NGjtdpNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBVSzN{IHPlcIx{Ng>? NIHPepo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NIH3T3-Luc MnzxSpVv[3Srb36gZZN{[Xl? NUPqOXhlOSC3TR?= MUW0PEBpenN? NFu5S2xKdmirYnn0bY9vKG:oIIPtc{1u\WSrYYTl[EBp\WSpZXjv[{B{cWewYXzpcocheGG2aIfhfUBqdiCvb4Xz[UBPUUh|VEOtUJVkKGOnbHzzJIF{e2W|c3XkJIF{KGSxd37y[Yd2dGG2aX;uJI9nKEeuaTDtVm5CKGW6cILld5Nqd25iYYSgNUB2VSCjZoTldkA1QCCqcoOgZpkhemWjbD30bY1mKFCFUjDhcoFtgXOrcz6= M4P3d|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEm5OFg{Lz5{OUS5PVQ5OzxxYU6=
C3H10T1/2 NFPU[HlHfW6ldHnvckBie3OjeR?= MYmyOEBpenN? M4HETmlvcGmkaYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XlvbXXkbYF1\WRiR1zJNUBuWk6DIHX4dJJme3Orb36gbY4hdW:3c3WgR|NJOTCWMT:yJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCUVD3QR3Ih[W6jbInzbZMhcW5icILld4Vv[2Vib3[gLFFTNDOjUjy0V{w4[VJrLUfhMY1mfGi7bD2xMUgpWilvNj3t[ZRpgWyqZYD0ZY4uOi27bDnvZ5RicHmmcn:tNWgucW6mZX6tOE16dCB|LXj5[JJwgHmkZX76c4F1\S5? NGrQbZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEezNFk5PCd-MkS3N|A6QDR:L3G+
C3H10T1/2 NUPCdoY1TnWwY4Tpc44h[XO|YYm= NUjyPFl3OjRiaILz NUjCcXdGUW6qaXLpeIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeT3t[YRq[XSnZDDHUGkyKG2UTlGg[ZhxemW|c3nvckBqdiCvb4Xz[UBEO0hzMGSxM|Ih[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IGLUMXBEWiCjbnHsfZNqeyCrbjDwdoV{\W6lZTDv[kBXTDNw MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd|MEm4OEc,OjR5M{C5PFQ9N2F-
NIH/3T3 M3:wSmZ2dmO2aX;uJIF{e2G7 MWKxNFAhdk1? NU\DPWxOOzZiaILz NWXyZoNDUW6qaXLpeIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeTDpckBud3W|ZTDOTWgwO1R|IHPlcIx{KGG|c3Xzd4VlKGG|IHTve45z\We3bHH0bY9vKG:oIGPobE1qdmS3Y3XkJGdtcTFibWLORUBmgHC{ZYPzbY9vKGyndnXsd{BifCBzMECgcm0h[W[2ZYKgN|YhcHK|IHL5JHJVNXGSQ2KgZY5idHm|aYOu MkXqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh6N{OzNFMoRjJ6OEezN|A{RC:jPh?=
C3H10T1/2 M13aRWZ2dmO2aX;uJIF{e2G7 NFixdlkyODBibl2= MnPCN|YhcHK| MVnJcohq[mm2aX;uJI9nKGinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGmwIH3veZNmKEN|SEGwWFEwOiClZXzsd{Bie3Onc4Pl[EBieyCmb4fudoVofWyjdHnvckBw\iCVaHitbY5lfWOnZDDHcIkyKG2UTlGg[ZhxemW|c3nvckBt\X[nbIOgZZQhOTByIH7NJIFnfGW{IEO2JIhzeyCkeTDSWE1yWEOUIHHuZYx6e2m|Lh?= MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDh5M{OwN{c,Ojh6N{OzNFM9N2F-
NIH/3T3 NF;pUWtHfW6ldHnvckBie3OjeR?= MVqxNFAhdk1? MmDBN|YhcHK| M{DuXmlvcGmkaYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XliaX6gcY92e2ViTlnIM|NVOyClZXzsd{Bie3Onc4Pl[EBieyCmb4fudoVofWyjdHnvckBw\iCVaHitbY5lfWOnZDDweINpOSCvUl7BJIV5eHKnc4Ppc44hdGW4ZXzzJIF1KDFyMDDuUUBi\nSncjCzOkBpenNiYomgVnQueVCFUjDhcoFtgXOrcz6= MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDh5M{OwN{c,Ojh6N{OzNFM9N2F-
C3H10T1/2 M3O5UGZ2dmO2aX;uJIF{e2G7 MUOxNFAhdk1? NWPsR3I1OzZiaILz NWXHdnlSUW6qaXLpeIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeTDpckBud3W|ZTDDN2gyOFRzL{KgZ4VtdHNiYYPz[ZN{\WRiYYOg[I94dnKnZ4XsZZRqd25ib3[gV4hpNWmwZIXj[YQheHSlaEGgcXJPSSCneIDy[ZN{cW:wIHzleoVteyCjdDCxNFAhdk1iYX\0[ZIhOzZiaILzJIJ6KFKWLYHQR3Ih[W6jbInzbZMv MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDh5M{OwN{c,Ojh6N{OzNFM9N2F-
medulloblastoma cell NHXLXIFCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NW\0[XVCfXBidH:gN|AhfU1? NGDZNHM4OiCqcoO= NFWxeY9CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JI1wfXOnIGD0Z4gsNy1icEWzMU8uKG2nZIXscI9jdGG|dH;tZUBk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iY3XscEBxem:uaX\ldoF1cW:wIIXwJJRwKDNyIIXNJIFnfGW{IEeyJIhzeyCkeTDNWHMh[XO|YYmu MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDh5M{OwN{c,Ojh6N{OzNFM9N2F-
medulloblastoma cell NGfUbFhCeG:ydH;zbZMh[XO|YYm= NV;mUoVIUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBud3W|ZTDQeINpMy9vIIC1N{0wNSCvZXT1cIxw[myjc4TvcYEh[2WubIOgbY1xdGGwdHXkJIlvKGG2aIntbYMhdnWmZTDtc5V{\SCjdDCxNk42KG2pL3vnMEBqeCCkaXSg[o9zKDF3IHPvcpNm[3W2aY\lJIRigXNiYomgWHVPTUxiYYPzZZkv M13LRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OEezN|A{Lz5{OEi3N|MxOzxxYU6=
NIH/3T3 M1X2V2Z2dmO2aX;uJIF{e2G7 MUTJcohq[mm2aX;uJI9nKGinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGW6cILld5Nm\CCrbjDtc5V{\SCQSVivN3Q{KGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gbIVl\2Wqb3etbY5lfWOnZDDHcIkuOiCjY3P1cZVt[XSrb36gZZQhfGmyIH;mJJBzcW2jcomgZ4ltcWFiYomgSGFRUSC|dHHpcolv\yCkYYPl[EBkd26ob3PhcEBucWO{b4Pjc5Bq[yCjbnHsfZNqey5? NHHIXnY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{ixNFU6OSd-Mke4NVA2QTF:L3G+
NIH/3T3 MkW3SpVv[3Srb36gZZN{[Xl? MYPJcohq[mm2aX;uJI9nKGinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGmwIH3veZNmKE6LSD:zWFMh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDo[YRo\WixZz3pcoR2[2WmIGPtc{1GT0[SIHPpcIlienlidILhcpNtd2OjdHnvckBjgSCGQWDJJJN1[WmwaX7nJIJie2WmIHPvcoZw[2GuIH3pZ5Jwe2OxcHnjJIFv[Wy7c3nzMi=> NHXrWlE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{ixNFU6OSd-Mke4NVA2QTF:L3G+
medulloblastoma cell MXLBcpRqNXS3bX;yJIF{e2G7 MXXBcpRqNXS3bX;yJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViUITjbEswNSCyNUOtM{0hdWWmdXzsc4Jt[XO2b33hJINmdGy|IHntdIxidnSnZDDpckBifGi7bXnjJI52\GVibX;1d4Uh[XO|ZYPz[YQh[XNidIXtc5Ih\3Kxd4ToJIlvcGmkaYTpc44h[XRiMkCgcYcwc2duIIDvJIFldWmwaYP0[ZJm\CC2d3nj[UBl[WmueTD2bYEh\2G4YXflJI1m[XO3cnXkJIV3\XK7IH;0bIVzKGSjeTDkeZJqdmdiY3;tdI92dmRiZH;zbY5oNg>? NF;FWWM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUezPVcyPCd-Mkm3N|k4OTR:L3G+
C3H10T1/2 MmjESpVv[3Srb36gZZN{[Xl? NIj5TFM1NjFidH:gNVAxOCCwTR?= NX71NWNvSWyub4P0[ZJq[yCrbnjpZol1cW:wIH;mJHNudyCrbjDtc5V{\SCFM1ixNHQyNzJiY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBxfXKvb4LwbIFucW6nLXnu[JVk\WRiR3zpNUB1emGwc3PybZB1cW:wYXygZYN1cX[rdImgZZQhPC5zIITvJFExODBibl2gZpkheVCFcjDhcoFtgXOrcz6= MoLaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyN{S1OFEoRjJ|MEe0OVQyRC:jPh?=
C3H10T1/2 MkLoSpVv[3Srb36gZZN{[Xl? M{HL[lQvOSC2bzCxNFAxKG6P M1zD[2NwdXCndHn0bZZmKGmwaHnibZRqd25ib3[gV41wKGmwIH3veZNmKEN|SEGwWFEwOiClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJHNCTy2rbnT1Z4VlKEeuaUGgeJJidnOlcnnweIlwdmGuIHHjeIl3cXS7IHH0JFQvOSC2bzCxNFAxKG6PIHL5JJFRS1JiYX7hcJl{cXNw MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzB5NEW0NUc,OjNyN{S1OFE9N2F-
Assay
Methods Test Index PMID
Western blot Bcl-2 / Bax ; p53 / Cyclin D1 / p21 ; Gli1 / SOX2 / OCT4 ; p-GSK3β / GSK3β / p-Akt / Akt / Gli1 ; Fas / DR4 / DR5 / Cleaved PARP / Bcl-2 / Cleaved caspase-3 / PDGFRα 28195165 26418365 27143997 22087285
Immunofluorescence Gli1 / Gli2 22087285
Growth inhibition assay Cell viability 29042665
In vivo GDC-0449 has been used to treat medulloblastoma in animal models. [2] GDC-0449 prevents the growth of primary pancreatic xenografts without non-specifically inhibiting pancreatic cell proliferation. Oral dosing of GDC-0449 causes tumor regressions in the Ptch(+/-) allograft model of medulloblastoma at doses ≥25 mg/kg and tumor growth inhibition at doses up to 92 mg/kg dosed twice daily in two ligand-dependent colorectal cancer models, D5123, and 1040830. Analysis of Hh pathway activity and PK/PD modeling reveals that GDC-0449 inhibits Gli1 with a similar IC50 in both the medulloblastoma and D5123 models (0.165 μM and 0.267 μM, respectively). Pathway modulation is linked to efficacy using an integrated PK/PD model revealing a steep relationship where > 50% of the activity of GDC-0449 is associated with >80% repression of the Hh pathway. [4]

Protocol (from reference)

Cell Research:[2]
  • Cell lines: MDCKII cells
  • Concentrations: 20 μM
  • Incubation Time: 2 hours
  • Method: MDCKII cells are seeded into 24-well plates at a density of 3 × 105 cells per well and are allowed to attach. Medium is then changed to that containing different drugs (50 μM VP, 50 μM indomethacin, or 20 μM GDC-0449 in DMSO or DMSO alone as control, and nonfluorescent calcein-AM is added to a final concentration of 1.0 μM and incubated at 37 °C for 2 hours. Cells are then washed twice with Ca2+, Mg2+-containing Hank's balanced salt solution buffer and lysed by shaking in 0.01% Triton X-100 in PBS buffer for 1 hour at room temperature or overnight at 4 °C. The lysate is then transferred into 96-well plates, and the fluorescence signal caused by the cell-derived calcein is quantified spectrophotometrically with a SpectraMax M5 Multi-Detection Readerusing an excitation wavelength of 495 nm and an emission wavelength of 515 nm. All manipulations are performed in the dark. All readings are expressed as mean ?SEM normalized to the control.
Animal Research:[4]
  • Animal Models: Ptch(+/-) allograft model, D5123 and 1040830
  • Dosages: ~ 100 mg/kg
  • Administration: Orally

Solubility (25°C)

In vitro

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
5% DMSO+40% PEG 300+5% Tween 80+50% ddH2O
For best results, use promptly after mixing.

12.5mg/mL

Chemical Information

Molecular Weight 421.3
Formula

C19H14Cl2N2O3S

CAS No. 879085-55-9
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03610022 Recruiting Drug: Treatment with vismodegib Metastatic Basal Cell Carcinoma|Locally Advanced Basal Cell Carcinoma University Hospital Bordeaux September 3 2018 Phase 4
NCT03035188 Unknown status Drug: Vismodegib Basal Cell Carcinoma SRH Wald-Klinikum Gera GmbH January 2017 Phase 2
NCT02781389 Completed -- Basal Cell Carcinoma University Hospital Essen|OnkoDataMed GmbH April 29 2016 --
NCT02593760 Completed Other: Placebo|Drug: Ruxolitinib|Drug: Vismodegib Myelofibrosis Hoffmann-La Roche January 25 2016 Phase 1
NCT02648048 Completed Drug: Pirfenidone|Drug: Vismodegib Idiopathic Pulmonary Fibrosis Hoffmann-La Roche January 15 2016 Phase 1
NCT02436408 Completed Drug: Vismodegib Carcinoma Basal Cell University of Michigan Rogel Cancer Center July 15 2015 Phase 4

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vismodegib|Vismodegib ic50|Vismodegib price|Vismodegib cost|Vismodegib solubility dmso|Vismodegib purchase|Vismodegib manufacturer|Vismodegib research buy|Vismodegib order|Vismodegib mouse|Vismodegib chemical structure|Vismodegib mw|Vismodegib molecular weight|Vismodegib datasheet|Vismodegib supplier|Vismodegib in vitro|Vismodegib cell line|Vismodegib concentration|Vismodegib nmr|Vismodegib in vivo|Vismodegib clinical trial|Vismodegib inhibitor|Vismodegib Stem Cells & Wnt inhibitor